| 000 | 01250 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250513130825.0 | ||
| 264 | 0 | _c19980122 | |
| 008 | 199801s 0 0 eng d | ||
| 022 | _a0724-8741 | ||
| 024 | 7 |
_a10.1023/a:1012189225880 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDavies, B E | |
| 245 | 0 | 0 |
_aThe pharmacokinetics of topotecan and its carboxylate form following separate intravenous administration to the dog. _h[electronic resource] |
| 260 |
_bPharmaceutical research _cOct 1997 |
||
| 300 |
_a1461-5 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBiological Availability |
| 650 | 0 | 4 | _aBiotransformation |
| 650 | 0 | 4 | _aDogs |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aInjections, Intravenous |
| 650 | 0 | 4 | _aTopoisomerase I Inhibitors |
| 650 | 0 | 4 |
_aTopotecan _xadministration & dosage |
| 700 | 1 | _aMinthorn, E A | |
| 700 | 1 | _aDennis, M J | |
| 700 | 1 | _aRosing, H | |
| 700 | 1 | _aBeijnen, J H | |
| 773 | 0 |
_tPharmaceutical research _gvol. 14 _gno. 10 _gp. 1461-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1023/a:1012189225880 _zAvailable from publisher's website |
| 999 |
_c9328810 _d9328810 |
||